Protagonist Therapeutics, Inc. (PTGX)
108.61
+2.84
(+2.69%)
USD |
NASDAQ |
Jun 11, 10:10
Protagonist Therapeutics EBITDA (TTM)
EBITDA (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBITDA (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -- |
| December 31, 2025 | -- |
| September 30, 2025 | -- |
| June 30, 2025 | -- |
| March 31, 2025 | -- |
| December 31, 2024 | -- |
| September 30, 2024 | -- |
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| Date | Value |
|---|---|
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
EBITDA Definition
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.
EBITDA (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median